Wellous
HomeMeRewardsReviewsProfilePolicy NoticeTerms & Conditions

Don't let our kidneys overwork! they're constantly filtering out toxins, but too much strain can wear them down ๐Ÿ˜“. Give the kidneys support they need with Spi2ro. Featuring powerful ingredients like ๐ŸŒฟ spirulina and chlorella โœจ that help to detoxify the body. Take care of our kidneys today, so they can keep taking care of us for years to come! ๐Ÿ’ช๐Ÿ’š

Don't let our kidneys overwork! they're constantly filtering out toxins, but too much strain can wear them down ๐Ÿ˜“. Give the kidneys support they need with Spi2ro. Featuring powerful ingredients like ๐ŸŒฟ spirulina and chlorella โœจ that help to detoxify the body. Take care of our kidneys today, so they can keep taking care of us for years to come! ๐Ÿ’ช๐Ÿ’š

Suggested For You

Attention all ZENSO superfans! ๐ŸŒŸ

Attention all ZENSO superfans! ๐ŸŒŸ

Think youโ€™ve got what it takes to solve this quiz? ๐Ÿง ๐Ÿ’ก

Drop your answers in the comments below! ๐Ÿ‘‡

Sensitive skin deserves both care and radiance! โœจ Femoire Day โ˜€๏ธ combines Chestnut Rose Extract for antioxidant protection, anti-inflammatory, and anti-aging benefits with Tolura Yeast Extract offering antioxidant defense, skin brightening, detoxification, and anti-inflammation. Together, they create a gentle, protective shield for delicate skin ๐Ÿ›ก๏ธ. Pair with Femoire Night ๐ŸŒ™ for around-the-clock protection and repair. Your skin will thank you! Start your journey to calm, radiant skin today with skin nourishing duo, Femoire Day & Night! ๐Ÿ’š๐Ÿ’–

Sensitive skin deserves both care and radiance! โœจ Femoire Day โ˜€๏ธ combines Chestnut Rose Extract for antioxidant protection, anti-inflammatory, and anti-aging benefits with Tolura Yeast Extract offering antioxidant defense, skin brightening, detoxification, and anti-inflammation. Together, they create a gentle, protective shield for delicate skin ๐Ÿ›ก๏ธ. Pair with Femoire Night ๐ŸŒ™ for around-the-clock protection and repair. Your skin will thank you! Start your journey to calm, radiant skin today with skin nourishing duo, Femoire Day & Night! ๐Ÿ’š๐Ÿ’–

๐ŸŽ‰ Wellous 2024: A Year of Milestones ๐ŸŽ‰

๐ŸŽ‰ Wellous 2024: A Year of Milestones ๐ŸŽ‰

Itโ€™s been an exciting year at Wellous, filled with achievements, new product launches, celebrations, and global engagements. From earning record-breaking sales to collaborating with iconic brands, we are proud to have made 2024 unforgettable! ๐Ÿ™Œ

A big thank you to each of our WellFam communities who supported us this year. We look forward to continuing this wellness journey with you in 2025! ๐Ÿ’š

What was your favorite Wellous moment of 2024? Let us know in the comments below!๐Ÿ‘‡

ๆƒณ่ฆไฟๆŒ่‚บ้ƒจๅฅๅบท๏ผŒ้ฆ–้€‰ๅคง้ฉฌ้”€้‡็ฌฌไธ€็š„ Tigrox ่™Žไนณ่Š๏ผ๐Ÿฏโœจ

ๆƒณ่ฆไฟๆŒ่‚บ้ƒจๅฅๅบท๏ผŒ้ฆ–้€‰ๅคง้ฉฌ้”€้‡็ฌฌไธ€็š„ Tigrox ่™Žไนณ่Š๏ผ๐Ÿฏโœจ

็”ฑ็ฒพ้€‰็š„ๅ›ฝๅฎ็บง่™Žไนณ่Š้…ๅˆถ่€Œๆˆ๏ผŒๆœ‰ๆ•ˆ็ผ“่งฃ้ผป็ชฆ็‚Žใ€ๅ’ณๅ—ฝใ€ๅ’ฝๅ–‰ไธ้€‚ๅ’Œๅ‘ผๅธ้“ๆ•ๆ„Ÿ็ญ‰้—ฎ้ข˜๏ผŒๅธฎๅŠฉไฝ ๅ’Œไฝ ็š„ๅฎถไบบๅฎ‰ๅฟƒๅ‘ผๅธ~๐Ÿ’š

Tigrox ่™Žไนณ่Šๅฑ…ๅฎถๅฟ…ๅค‡๏ผŒไธบ็™พไธ‡ๅฆˆๅฆˆไฟๆŠคๅฎถไบบๅฅๅบท๏ผ๐Ÿ‘จโ€๐Ÿ‘ฉโ€๐Ÿ‘งโ€๐Ÿ‘ฆ

Game on! ๐Ÿฆ‘

Game on! ๐Ÿฆ‘

Say goodbye to creaky knees and hello to smooth, sweet victories!

With MoveOn and LiveOn, youโ€™re always on top of the game - no matter what life serves you.

Did You Know?๐Ÿค” Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Did You Know?๐Ÿค” Nearly 40% of Malaysian adults have non-alcoholic fatty liver disease (NAFLD), the most common liver issue in the country.

Our latest newsletter dives deep into understanding liver health! You'll explore a range of common liver conditions, the ways to prevent viral hepatitis and fatty liver, and our featured products - LIVETAL & HOMEGA to support your liver health. Also, don't miss out on our Digital Detox Challenge to give your mind and body a break!๐Ÿงกโœจ

Click the link below to access the full newsletter and learn more about keeping your liver healthy!๐Ÿฅฐ

๐Ÿ‘‰ https://cdn.wellous.com/membership/article/newsletter/2024/2024-q2-en.pdf